Dynorphin and epilepsy

Progress in Neurobiology

Volumn 50, Issue 5-6, 1996, Pages 557-583

  Simonato, Michele ^a   Romualdi, Patrizia ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DYNORPHIN; ENADOLINE; N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZO[B]THIOPHENE 4 ACETAMIDE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST; OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ELECTROPHYSIOLOGY; EPILEPSY; FOCAL EPILEPSY; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; KINDLING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; TONIC CLONIC SEIZURE;

EID: 0030481295     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(96)00045-7     Document Type: Article

References (233)

1. Akil, H., Watson, S. J., Young, E., Lewis, M. E., Khachaturian, H. and Walker, J. M. (1984) Endogenous opioids: biology and function. Ann. Rev. Neurosci. 7, 223-255.
2. Amado, D., Cavalheiro, E. A. and Bentivoglio, M. (1993) Epilepsy and hormonal regulation: the patterns of GnRh and galanin immunoreactivity in the hypothalamus of epileptic female rats. Epilepsy Res. 14, 149-159.
3. Anderson, K. D. and Reiner, A. (1990) Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionary conserved feature of basal ganglia organization. J. Comp. Neurol. 295, 330-369.
4. Antkiewicz-Michatuk, L., Rokosz-Pelc, A. and Vetulani, J. (1984) Effect of electroconvulsive treatment on cerebral opioid receptors in the rat: changes in δ but not μ receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 328, 87-89.
5. Babb, T. L., Kupfer, W. R., Pretorius, J. K., Crandall, P. H. and Levesque, M. F. (1991) Synaptic reorganization by mossy fibers in human epileptic fascia dentata. Neuroscience 42, 351-363.
6. Bean, B. P. (1989) Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature 340, 153-156.
7. Berman, Y. L., Juliano, L. and Devi, L. A. (1995) Purification and characterization of a dynorphin-processing endopeptidase. J. Biol. Chem. 270, 23845-23850.
8. Biossier, J. R., Simon, P., Villeneuve, A. and Larouse, C. (1968) Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs. Can. J. Physiol. Pharmacol. 46, 93-100.
9. Candeletti, S. and Ferri, S. (1995) Cerebrospinal alterations of immunoreactive dynorphin A after unilateral dorsal rhizotomy in the rat. Brain Res. 670, 289-296.
10. Caudle, R. M. and Isaac, L. (1988) A novel interaction between dynorphin (1-13) and an N-methyl-D-aspartate site. Brain Res. 443, 329-332.
11. Cavazos, J. E., Golarai, G. and Sutula, T. P. (1991) Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence. J. Neurosci. 11, 2795-2803.
12. Chavkin, C., James, I. F. and Goldstein, A. (1982) Dynorphin is a specific endogenous ligand of the κ opioid receptor. Science 215, 413-415.
13. Chen, L., Gu, Y. and Huang, L. Y. (1995) The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin. J. Neurosci. 15, 4602-4611.
14. Chen, Y., Mestek, A., Liu, J., Hurley, J. A. and Yu, L. (1993) Molecular cloning and functional expression of a μ opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
15. Cheng, J. G. and Xie, X. K. (1990) A study on opioid peptides in CSF of patients with epilepsy. Epilepsy Res. 6, 141-145.
16. Chrétien, M. and Li, C. H. (1967) Isolation and purification of γ lipotropic hormone from sheep pituitary glands. Can. J. Biochem. 45, 1163.
17. Civelli, O., Douglass, J., Goldstein, A. and Herbert, E. (1985) Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. USA 82, 4291-4295.
18. Cole, R. L., Konradi, C., Douglass, J. and Hyman, S. E, (1995) Neuronal adaption to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14, 813-823.
19. Collard, M. W., Day, R., Akil, H., Uhler, M. D. and Douglass, J. O. (1990) Sertoli cells are the primary site of prodynorphin gene expression in rat testis: regulation of mRNA synthesis and peptide secretion by cAMP analogs in cultured cells. Mol. Endocrinol. 4, 1488-1496.
20. Commission on Classification and Terminology of the International League Against Epilepsy (1981) Proposal for revised clinical and electro-encephalographic classification of epileptic seizures. Epilepsia 22, 489-501.
21. Commission on Classification and Terminology of the International League Against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic seizures. Epilepsia 30, 389-399.
22. Coulter, D. A. (1996) Thalamocortical anatomy and physiology. In: Epilepsy: a comprehensive textbook. Eds. J. Engel and T. A. Pedley. Raven Press: New York.
23. Cox, B. M. (1993) Opioid receptor-G protein interactions: acute and chronic effects of opioids. In: Opioids I, Vol. 1, pp. 145-188. Ed. A. Herz. Springer-Verlag: Berlin.
24. Coyle, J. T., Molliver, M. E. and Kuhar, M. J. (1978) In situ injection of kainic acid: a new method for selectively lesioning neuronal cell bodies while sparing axons of passage. J. Comp. Neurol. 180, 301-323.
25. Crain, B. J., Chang, K. J. and McNamara, J. O. (1987) An in vitro autoradiographic analysis of mu and delta opioid binding in the hippocampal formation of kindled rats. Brain Res. 412, 343-351.
26. Cronin, J. and Dudek, F. E. (1988) Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats. Brain Res. 474, 181-184.
27. Day, R. and Akil, H. (1986) Bridge peptide is a cleavage product of prodynorphin processing in the rat anterior pituitary. Natl. Inst. Drug Abuse Res. Monogr. Ser. 75, 244-246.
28. Day, R. and Akil, H. (1989) The posttranslational processing of prodynorphin in the rat anterior pituitary. Endocrinology 124, 2392-2405.
29. Day, R., Schäfer, M. K.-H., Collard, M. W., Watson, S. J. and Akil, H. (1991) Atypical prodynorphin gene expression in corticosteroid producing cells of the rat adrenal gland. Proc. Natl. Acad. Sci., USA 88, 1320-1324.
30. Day, R., Trujillo, K. A. and Akil, H. (1993) Prodynorphin biosynthesis and posttranslational processing. In: Opioids I, Vol. I, pp. 449-470. Ed. A. Herz. Springer-Verlag: Berlin.
31. de Lanerolle, N. C., Kim, J. K., Robbins, R. J. and Spencer, D. D. (1989) Hippocampal interaeuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495, 387-395.
32. de Lanerolle, N. C., Brines, M., Williamson, A., Kim, J. H. and Spencer, D. D. (1992) Neurotransmitters and their receptors in human temporal lobe epilepsy. Epilepsy Res. 7, suppl., 235-250.
33. De Sarro, G., Trimarchi, G. R., Sinopoli, S., Masuda, Y. and De Sarro, A. (1993) Anticonvulsant effects of U-54494A and U-51488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex. Gen. Pharmacol. 24, 439-447.
34. Devi, L. (1991) Consensus sequence for processing of peptide precursor at monobasic sites. Febs Lett. 280, 189-194.
35. Devi, L. (1993) Tissue distribution of a dynorphin-processing endopeptidase. Endocrinology 132, 1139-1144.
36. Devi, L. and Goldstein, A. (1984) Dynorphin converting enzyme with unusual specificity from rat brain. Proc. Natl. Acad. Sci. USA 81, 1892-1896.
37. Dingledine, R., McBain, C. J. and McNamara, J. O. (1990) Excitatory amino acid receptors in epilepsy. Trends Pharmacol. Sci. 11, 334-338.
38. Douglass, J., Cox, B., Quinn, B., Civelli, O. and Herbert, E. (1987) Expression of the prodynorphin gene in male and female mammalian reproductive tissues. Endocrinology 120, 707-713.
39. Douglass, J., McMurray, C. T., Garrett, J. E., Adelman, J. P. and Calavetta, L. (1989) Characterization of the rat prodynorphin gene. Mol. Endocrinol. 3, 2070-2078.
40. Douglass, J., Grimes, L., Shook, J., Lee, P. H. and Hong, J. S. (1991) Systemic administration of kainic acid differentially regulates the levels of prodynorphin and proenkephalin mRNA and peptides in the rat hippocampus. Mol. Brain Res. 9, 79-86.
41. Douglass, J., McKinzie, A. A. and Pollock, K. M. (1994) Identification of multiple Dna elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol. Endocrinol. 8, 333-344.
42. Dragunow, M. and Robertson, H. A. (1987) Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus. Nature 329, 441-442.
43. Drake, C. T., Terman, G. W., Simmons, M. L., Milner, T. A., Kunkel, D. D., Schwartzkroin, P. A. and Chavkin, C. (1994) Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J. Neurosci. 14, 3736-3750.
44. Dubner, R. and Ruda, M. A. (1992) Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15, 96-103.
45. Ehlers (1984) Role of selected neuropeptides in the development of epileptiform discharges. In: Neurotransmitters, seizures and epilepsy II, pp. 295-304. Eds. R. G. Fariello, P. L. Morselli, K. G. Lloyd, L. F. Quisney and J. Engel, Jr. Raven Press: New York.
46. Elde, R. and Hökfelt, T. (1993) Coexistence of opioid peptides with other neurotransmitters. In: Opioids I, Vol. I, pp. 585-624. Ed. A. Herz. Springer-Verlag: Berlin.
47. Engel, J., Wolfson, L. and Brown, L. (1978) Anatomical correlates of electrical and behavioural events related to amygdaloid kindling. Ann. Neurol. 3, 538-544.
48. Engel, J., Ackermann, R. F., Caldecott-Hazard, S. and Chugani, H. T. (1984) Do altered opioid mechanisms play a role in human epilepsy? In: Neurotransmitters, seizures and epilepsy II, pp. 263-272. Eds. R. G. Fariello, P. L. Morselli, K. G. Lloyd, L. F. Quisney and J. Engel, Jr. Raven Press: New York.
49. Evans, C. J., Keith, D. E. Jr., Morrison, H., Magendzo, K. and Edwards, R. H. (1992) Cloning of a delta opioid receptor by functional expression. Science 258, 1952-1955.
50. Everitt, B. J., Meister, B., Hokfelt, T., Melander, T., Terenius, L., Rokaeus, A., Theodorsson-Norheim, E., Dockray, G., Edwardson, J., Cuello, C., Elde, R., Goldstein, M., Hemmings, H., Ouimet, C., Walaas, I., Greengard, P., Vale, W., Weber, E., Wu, J.-Y, and Chang, K.-J. (1986) The hypothalamic arcuate nucleus-median eminence complex: immunohistochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons. Brain Res. Rev. 11, 97-155.
51. Fischer, W., Bodewei, R., Von Voigtlander, P. F. and Muller, M. (1993) Anticonvulsant and related effects of U-54494A in various seizure tests. J. Pharmacol. Exp. Ther. 267, 163-170.
52. Fischli, W., Goldstein, A., Hunkapiller, M. W. and Hood, L. E. (1982a) Isolation and amino acid sequence analysis of a 4000-dalton dynorphin from porcine pituitary. Proc. Natl. Acad. Sci. USA 79, 5435-5437.
53. Fischli, W., Goldstein, A., Hunkapiller, M. W. and Hood, L. E. (1982b) Two "big" dynorphins from porcine pituitary. Life Sci. 31, 1769-1772.
54. Fisher, R. S. (1989) Animal models of the epilepsies. Brain Res. Rev. 14, 245-278.
55. Frenk, H. (1983) Pro-and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res. Rev. 6, 197-210.
56. Frey, H. H. (1988) Effect of mu-and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266. Pharmacol. Toxicol. 62, 150-154.
57. Frost, J. J., Mayberg, H. S., Fisher, R. S., Douglass, K. H., Dannals, R. F., Links, J. M., Wilson, A. A. and Ravert, H. T. (1988) Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann. Neurol. 23, 231-237.
58. Gall, C. (1988) Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibers. J. Neurosci. 8, 1852-1862.
59. Gall, C., Lauterborn, J., Burks, D. and Seroogy, K. (1987) Co-localization of enkephalin and cholecistokinin in discrete areas of rat brain. Brain Res. 403, 403-408.
60. Gall, C., Lauterborn, J., Isackson, P. and White, J. (1990) Seizures, neuropeptide regulation, and mRNA expression in the hippocampus. Prog. Brain Res. 83, 371-390.
61. Gannon, R. L. and Terrian, D. M. (1991) Presynaptic modulation of glutamate and dynorphin release by excitatory amino acids in the guinea-pig hippocampus. Neuroscience 41, 401-410.
62. Goddard, G. V. (1967) Development of epileptic seizures through brain stimulation at low intensity. Nature 214, 1020-1021.
63. Goldstein, A. (1994) Addiction: from biology to drug policy. Freeman: New York.
64. Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M. and Hood, L. (1979) Dynorphin-(1-13), an extraordinarly potent opioid peptide. Proc. Natl. Acad. Sci. USA 76, 6666-6670.
65. Goldstein, A., Fischli, W., Lowney, L. I., Hunkapiller, M. and Hood, L. (1981) Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc. Natl. Acad. Sci. USA 78, 7219-7223.
66. Graybiel, A. M. (1986) Neuropeptides in the basal ganglia. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 64, 135-161.
67. Gross, R. A. and McDonald, R. L. (1987) Dynorphin A selectively reduces a large transient N-type calcium current of mouse dorsal root ganglion neurons in cell culture. Proc. Natl. Acad. Sci. USA 84, 5469-5473.
68. Grudt, T. J. and Williams, J. T. (1993) Kappa opioid receptors also increase potassium conductance. Proc. Natl. Acad. Sci. USA 90, 11429-11432.
69. Harrison, M. B., Shumate, M. D. and Lothman, E. W. (1995) Opioid peptide expression in models of chronic temporal lobe epilepsy. Neuroscience 65, 785-795.
70. Helton, T. E. and McGinty, J. F. (1993) Intrahippocampal Nmda administration alters Fos, Fos-related antigens, and opioid peptide immunoreactivity and mRNA in rats. Mol. Cell. Neurosci. 4, 319-334.
71. Helton, T. E., Daunais, J. B. and McGinty, J. F. (1993) Convulsant doses of cocaine alter immediate early gene and opioid peptide expression in rat limbic forebrain. Mol. Brain Res. 20, 285-288.
72. Henriksen, S. J., Bloom, F. E., McCoy, F., Ling, N. and Guillemin, R. (1978) Beta-endorphin induces nonconvulsive limbic seizures. Proc. Natl. Acad. Sci. USA 75, 5221-5225.
73. Herman, B. H., Leslie, F. and Goldstein, A. (1980) Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-ala2-dynorphin-(1-11) in rats. Life Sci. 27, 883-888.
74. Hokfelt, T. (1991) Neuropeptides in perspective: the last ten years. Neuron 7, 867-879.
75. Höllt, V. (1983) Multiple endogenous opioid peptides. Trends Neurosci. 6, 24-26.
76. Höllt, V. (1993) Regulation of opioid peptide gene expression. In: Opioids I, Vol. I, pp. 307-346. Ed. A. Herz. Springer-Verlag: Berlin.
77. Hong, J. S., McGinty, J. F., Lee, P. H. K., Xie, C. W. and Mitchell, C. L. (1993) Relationship between hippocampal opioid peptides and seizures. Prog. Neurobiol. 40, 507-528.
78. Hosford, D. A., Crain, B. J., Cao, Z., Bonhaus, D. W., Friedman, A. H., Okazaki, M. M., Nadler, J. V. and McNamara, J. O. (1991) Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampus. J. Neurosci. 11, 428-434.
79. Hosford, D. A., Simonato, M., Cao, Z., Garcia-Cairasco, N., Silver, J. M., Butler, L., Shin, C. and McNamara, J. O. (1995) Differences in the anatomic distribution of immediate early gene expression in amygdala and angular bundle kindling development. J. Neurosci. 15, 2513-2523.
80. Horikawa, S., Takai, T., Toyosato, M., Takahashi, H., Noda, M., Kakidani, H., Kubo, T., Hirose, T., Inayama, S., Hayashida, H., Miyata, T. and Numa, S. (1983) Isolation and structural organization of the human preproenkephalin B gene. Nature 306, 611-614.
81. Houser, C. R., Miyashiro, J. E., Swartz, B. E., Walsh, G. O., Rich, J. R. and Delgrado-Escueta, A. V. (1990) Altered pattrens of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J. Neurosci. 10, 267-282.
82. Hughes, P. and Dragunow, M. (1995) Induction of immediate early genes and the control of neurotransmitter-regulated gene expression in the central nervous system. Pharmacol. Rev. 47, 133-178.
83. Iadarola, M. J., Douglass, J., Civelli, O. and Naranjo, J. R. (1986a) Increased spinal cord dynorphin mRNA during peripheral inflammation. Natl. Inst. Drug Abuse Res. Monogr. Ser. 75, 406-409.
84. Iadarola, M. J., Shin, C., McNamara, J. O. and Yang, Y. T. (1986b) Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling. Brain Res. 365, 185-191.
85. Isokawa, M., Levesque, M. F., Babb, T. L. and Engel, J. Jr. (1993) Single mossy fiber axonal systems of human dentate granule cells studied in hippocampal slices from patients with temporal lobe epilepsy. J. Neurosci. 13, 1511-1522.
86. Jackson, H. C. and Nutt, D. J. (1991) Differential effects of selective mu-, kappa-and delta-opioid antagonists on electroshock seizure threshold in mice. Psychopharmacology 103, 380-383.
87. Kakidani, H., Furutani, Y., Takahashi, H., Noda, M., Morimoto, Y., Hirose, T., Asai, M., Inayama, S., Nakanishi, S. and Numa, S. (1982) Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature 298, 245-249.
88. Kanamatsu, T., McGinty, J. F., Mitchell, C. L. and Hong, J. S. (1986a) Dynorphin-and enkephalin-like immunoreactivity is altered in limbic-basal ganglia regions of rat brain after repeated electroconvulsive shock. J. Neurosci. 6, 644-649.
89. Kanamatsu, T., Obie, J., Grimes, L., McGinty, J. F., Yoshikawa, K., Sabol, S. and Hong, J. S. (1986b) Kainic acid alters the metabolism of met5-enkephalin and the level of dynorphin A in the rat hippocampus. J. Neurosci. 6, 3094-3102.
90. Kangawa, K. and Matsuo, H. (1979) Alpha-neo-endorphin: a "big" Leu-enkephalin with potent opiate activity from porcine hypothalami. Biochem. Biophys. Res. Commun. 86, 153-160.
91. Kangawa, K., Minamino, N., Chino, N., Sakakibara, S. and Matsuo, H. (1981) The complete ammino acid sequence of alpha-neo-endorphin. Biochem. Biophys. Res. Commun. 99, 871-878.
92. Karler, R., Calder, L. D., Chaudhry, I. A. and Turkanis, S. A. (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45, 599-606.
93. Khachaturian, H., Sherman, T. G., Lloyd, R. V., Civelli, O., Douglass, J., Herbert, E., Akil, H. and Watson, S. J. (1986) Prodynorphin is endogenous to the anterior pituitary and is co-localized with LH and FSH in the gonadotrophs. Endocrinology 119, 1409-1411.
94. Khachaturian, H., Schaefer, M. K. H. and Lewis, M. E. (1993) Anatomy and function of the endogenous opioid system. In: Opioids I, Vol. I, pp. 471-497. Ed. A. Herz. Springer-Verlag: Berlin.
95. Kilpatrick, D. L., Wahlstrom, A., Lahm, H. W., Blacher, R., Ezra, E., Fleminger, G. and Udenfriend, S. (1982a) Characterization of rimorphin, a new [leu]enkephalin-containing peptide from bovine posterior pituitary glands. Life Sci. 31, 1849-1852.
96. Kilpatrick, D. L., Wahlstrom, A., Lahm, H. W., Blacher, R. and Udenfriend, S. (1982b) Rimorphin, a unique, naturally occurring [Leu]enkephalin-containing peptide found in association with dynorphin and alpha-neo-endorphin. Proc. Natl. Acad. Sci. USA 79, 6480-6483.
97. Koella, W. P. (1985) Animal experimental methods in the study of antiepileptic drugs. In: Antiepileptic drugs, pp. 283-339. Eds. H. H. Frey and D. Janz. Springer-Verlag: Berlin.
98. Kolaj, M., Cerne, R. and Randic, M. (1995) The opioid peptide dynorphin modulate Ampa and kainate responses in acutely isolated neurons from the dorsal horn. Brain Res. 671, 227-244.
99. Labiner, D. M., Butler, L. S., Cao, Z., Hosford, D. A., Shin, C. and McNamara, J. O. (1993) Induction of c-fos mRNA by kindled seizures: complex relationship with neuronal burst firing. J. Neurosci. 13, 744-751.
100. Laorden, M. L., Olaso, M. J., Miralles, F. S. and Puig, M. M. (1985) Cerebrospinal fluid leucine-enkephalin-like levels in febrile convulsions. Meth. Find. Exp. Clin. Pharmacol. 7, 75-77.
101. La Salle, G. L. G. (1988) Long-lasting and sequential increase of c-fos oncoprotein expression in kainic acid-induced status epilepticus. Neurosci. Lett. 88, 127-130.
102. Lasoń, W., Przewłocka, B. and Przewłocka, R. (1992a) The effects of excitatory amino acids on proenkephalin and prodynorphin mRNA levels in the hippocampal dentate gyms of the rat; an in situ hybridization study. Mol. Brain Res. 12, 243-247.
103. Lasoń, W., Przewł, B. and Przewł, R. (1992b) The prodynorphin system in the rat hippocampus is differentially influenced by kainic acid and pentetrazole. Neuroscience 51, 357-362.
104. Lee, R. J., McCabe, R. T., Wamsley, J. K., Olsen, R. W. and Lomax, P. (1986) Opioid receptor alterations in a genetic model of generalized epilepsy. Brain Res. 380, 76-82.
105. Lee, R. J., Hong, J. S., McGinty, J. F. and Lomax, P. (1987) Increased enkephalin and dynorphin immunoreactivity in the hippocampus of seizure sensitive Mongolian gerbils. Brain Res. 401, 353-358.
106. Lee, P. H. K., Zhao, D., Xie, C. W., McGinty, J. F., Mitvhell, C. L. and Hong, J. S. (1989) Changes of proenkephalin and prodynorphin mRNAs and related peptides in rat brain during the development of deep prepyriform cortex kindling. Mol. Brain Res. 6, 263-273.
107. Leng, G., Bicknell, R. J., Brown, D., Bowden, C., Chapman, C. and Russell, J. A. (1994) Stimulus-induced depletion of pro-enkephalins, oxytocin and vasopressin and pro-enkephalin interaction with posterior pituitary hormone release in vitro. Neuroendocrinology 60, 559-566.
108. Li, S. J., Sivam, S. P., McGinty, J. F., Jiang, H. K., Douglass, J., Calavetta, L. and Hong, J. S. (1988) Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J. Pharmacol. Exp. Ther. 246, 403-408.
109. Long, J. B., Martinez, A. A., Echevarria, E. E., Tidwell, R. E. and Holaday, J. W. (1988) Hindlimb paralytic effects of prodynorphin-derived peptides following spinal subarachnoid injection in rats. Eur. J. Pharmacol. 153, 45-54.
110. Lothman, E. W., Collins, R. C. and Ferrendelli, J. A. (1981) Kainic acid-induced limbic seizures: electroencephysiologic studies. Neurology 31, 806-812.
111. Lucas, J. J., Mellström, B., Colado, M. I. and Naranjo, J. R. (1993) Molecular mechanisms of pain: serotonin1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons. Neuron 10, 599-611.
112. Mansour, A. and Watson, S. J. (1993) Anatomical distribution of opioid receptors in mammalians: an overview. In: Opioids I, Vol. I, pp. 79-105. Ed. A. Herz. Springer-Verlag: Berlin.
113. Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H. and Watson, S. J. (1987) Autoradiographic differentation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7, 2445-2464.
114. Mansour, A., Fox, C. A., Akil, H. and Watson, S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29.
115. Martin, W. E. (1983) Pharmacology of opioids. Pharmacol. Rev. 35, 283-323.
116. Mayberg, H. S., Sadzot, B., Meltzer, C. C., Fisher, R. S., Lesser, R. P., Dannals, R. F., Lever, J. R., Wilson, A. A., Ravert, H. T., Wagner, H. N. Jr., Bryan, R. N., Cromwell, C. C. and Frost, J. J. (1991) Quantification of μ and non-μ opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann. Neurol. 30, 3-11.
117. McGinty, J. F., Henriksen, S. J., Goldstein, A., Terenius, L. and Bloom, F. E. (1983) Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 80, 589-593.
118. McGinty, J. F., Kanamatsu, T., Obie, J., Dyer, R. S., Mitchell, C. L. and Hong, J. S. (1986) Amygdaloid kindling increases enkephalin-like immunoreactivity but decreases dynorphin-A-like immunoreactivity in rat hippocampus. Neurosci. Lett. 71, 31-36.
119. McMurray, C. T., Pollock, K. M. and Douglass, J. (1992) Cellular and molecular analysis of opioid peptide gene expression. NIDA Res. Monogr. 113, 113-131.
120. McNamara, J. O. (1984) Kindling: an animal model of complex partial epilepsy. Ann. Neurol. 16, Suppl., 72-76.
121. McNamara, J. O. (1988) Pursuit of the mechanism of kindling. Trends Neurosci. 11, 33-36.
122. McNamara, J. O. (1994) Cellular and molecular basis of epilepsy. J. Neurosci. 14, 3413-3425.
123. McNamara, J. O., Russel, R. D., Rigsbee, L. and Bonhaus, D. W. (1988) Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 27, 563-568.
124. McNamara, J. O., Bonhaus, D. W. and Shin, C. (1993) The kindling model of epilepsy. In: Concepts and models in epilepsy research, pp. 27-47. Ed. P. Schwartzkroin. Cambridge University Press: New York.
125. Meister, B., Villar, M. J., Ceccatelli, S. and Hokfelt, T. (1990) Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations. Neuroscience 37, 603-633.
126. Messersmith, D. J., Gu, Y., Dubner, R., Douglass, J. and Iadarola, M. J. (1994) Basal and inducible transcriptional activity of an upstream AP-1/CRE element (DynCRE3) in the prodynorphin promoter. Mol. Pharmacol. 5, 238-245.
127. Meunier, J.-C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.-L., Guillemot, J.-C., Ferrara, P., Monserrat, B., Marzarguil, H., Vassart, G., Parmentier, M. and Costentin, J. (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535.
128. Minamino, N., Kangawa, K., Fukuda, A., Matsuo, H. and Lagarashi, M. (1980) A new opioid octapeptide related to dynorphin from porcine hypothalamus. Biochem. Biophys. Res. Commun. 95, 1475-1481.
129. Minamino, N., Kangawa, K., Chino, N., Sakakibara, S. and Matsuo, H. (1981) Beta-neo-endorphin, a new hypothalamic "big" leu-enkephalin of porcine origin: its purification and the complete amino acid sequence. Biochem. Biophys. Res. Commun. 99, 864-870.
130. Molaie, M. and Kadzielawa, K. (1989) Effect of naloxone infusion on the rate of epileptiform discharges in patients with complex partial seizures. Epilepsia 30, 194-200.
131. Moneta, M. E. and Höllt, V. (1990) Perforant path kindling induces differential alterations in the mRNA levels coding for prodynorphin and proenkephalin in the rat hippocampus. Neurosci. Lett. 110, 273-278.
132. Montplaisir, J., Saint-Hilaire, J. M., Walsh, J. T., Laverdiere, N. and Bouvier, G. (1981) Naloxone and focal epilepsy: a study with depth electrodes. Neurology 31, 350-352.
133. Morris, B. J. and Johnston, H. M. (1995) A role for hippocampal opioids in long-term functional plasticity. Trends Neurosci. 18, 350-355.
134. Morris, B. J., Haarmann, I., Kempter, B., Höllt, V. and Herz, A. (1986) Localization of prodynorphin messenger RNA in rat brain by in situ hybridization using a synthetic oligonucleotide probe. Neurosci. Lett. 69, 104-108.
135. Morris, B. J., Moneta, M. E., ten Bruggencate, G. and Höllt, V. (1987) Levels of prodynorphin mRNA in rat dentate gyrus are decreased during hippocampal kindling. Neurosci. Lett. 80, 298-302.
136. Morris, B. J., Höllt, V. and Herz, A. (1988a) Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA. Neuroscience 25, 525-532.
137. Morris, B. J., Reimer, S., Höllt, V. and Herz, A. (1988b) Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway. Brain Res. 464, 15-22.
138. Nadler, J. V., Perry, B. W. and Cotman, C. W. (1980) Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid. Brain Res. 182, 1-9.
139. Nakata, Y., Chang, K. J., Mitchell, C. L. and Hong, J. S. (1985) Repeated electroconvulsive shock downregulates the opioid receptors in rat brain. Brain Res. 346, 160-163.
140. Naranjo, J. R., Mellström, B., Achaval, M. and Sassone-Corsi, P. (1991) Molecular pathways of pain: fos/jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron 6, 606-617.
141. Neal, C. J., Swann, J. M. and Newman, S. W. (1989) The colocalization of substance P and prodynorphin immunoreactivity in neurons of the medial preoptic area, bed nucleus of the stria terminalis and medial nucleus of the amygdala of the Syrian hamster. Brain Res. 496, 1-13.
142. Olsen, R. W. (1981) The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs. Mol. Cell. Biochem. 39, 261-279.
143. Onishi, H., Soma, T., Yamagami, S. and Kawakita, Y. (1989) Alteration of opioid receptors in seizure-susceptible E1 mouse brain. Neurochem. Res. 14, 31-35.
144. Palkovits, M. (1995) Neuropeptide messenger plasticity in the CNS neurons following axotomy. Mol. Neurobiol. 10, 91-103.
145. Pan, Y. X., Cheng, J., Xu, J., Rossi, G., Jacobson, E., Ryan-Moro, J., Brooks, A. I., Dean, G. E., Standifer, K. M. and Pasternak, G. W. (1995) Cloning and functional characterization through antisense mapping of a κ3-related opioid receptor. Mol. Pharmacol. 47, 1180-1188.
146. Pellegrino, L. J., Pellegrino, A. S. and Cushman, A. J. (1979) A stereotaxic atlas of the rat brain. Plenum Press: New York.
147. Pennypacker, K. R., Walczak, D., Thai, L., Fannin, R., Mason, E., Douglass, J. and Hong, J. S. (1993) Kainate-induced changes in opioid peptide genes and AP-1 protein expression in the rat hippocampus. J. Neurochem. 60, 204-211.
148. Perry, D. C. and Grimes, L. M. (1989) Administration of kainic acid and colchicine alters mu and lambda opiate binding in rat hippocampus. Brain Res. 477, 100-108.
149. Pert, C. B. and Snyder, S. H. (1973) Opiate receptor: demonstration in nervous tissue. Science 179, 1011-1014.
150. Pinel, J. P. J. and Rovner, L. I. (1978) Experimental epileptogenesis: kindling-induced epilepsy in rats. Exp. Neurol. 58, 190-202.
151. Pitkanen, A., Jolkkonen, J. and Riekkinen, P. (1987) Beta-endorphin, somatostatin, and prolactin levels in cerebrospinal fluid of epileptic patients after generalized convulsion. J. Neurol. Neurosurg. Psych. 50, 1294-1297.
152. Pittius, C. W., Kley, N., Loeffler, J. P. and Höllt, V. (1987) Proenkephalin B messenger RNA in porcine tissues: characterization, quantification, and correlation with opioid peptides. J. Neurochem. 48, 586-592.
153. Popovici, T., Represa, A., Crepel, V., Barbin, G., Beaudoin, M. and Ben-Ari, Y. (1990) Effects of kainic acid-induced seizures and ischemia on c-fos-like proteins in rat brain. Brain Res. 536, 183-194.
154. 11C]diprenorphine and positron emission tomography. Epilepsy Res. 19, 71-77.
155. Przewlocka, B., Lasoń, W., Machelska, H., VanLuijtelaar, G., Coenen, A. and Przewlocki, R. (1995) Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats. Neurosci. Lett. 186, 131-136.
156. Przewlocki, R., Haarmann, I., Nikolarakis, K., Herz, A. and Höllt, V. (1988) Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat. Brain Res. 464, 37-41.
157. Racine, R. J. (1972) Modification of seizure activity by electric stimulation II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281-294.
158. Reece, P. A., Sedman, A. J., Rose, S., Wright, D. S., Dawkins, D. S. and Rajagopalan, R. (1994) Diuretic effects, pharmacokinetics and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans. J. Clin. Pharmacol. 34, 1126-1132.
159. Reinscheid, R. K., Nothacker, H.-P., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., Grandy, D. K., Langen, H., Monsma, F. J. Jr. and Civelli, O. (1995) Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270, 792-794.
160. Represa, A., Le Gall La Salle, G. and Ben-Ari, Y. (1989) Hippocampal plasticity in the kindling model of epilepsy in rats. Neurosci. Lett. 99, 345-350.
161. Rocha, L., Ackermann, R. F., Nassir, Y., Chugani, H. T. and Engel, J. Jr. (1993) Characterization of mu opioid receptor binding during amygdala kindling in rats and effects of chronic naloxone pretreatment: an autoradiographic study. Epilepsy Res. 14, 195-208.
162. Rogawski, M. A. and Porter, R. J. (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42, 223-286.
163. Romualdi, P., Lesa, G. and Ferri, S. (1991) Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain. Brain Res. 63, 132-136.
164. Romualdi, P., Lesa, G., Donatini, A., Balboni, G., Tomatis, R. and Ferri, S. (1992) Alterations in vasoactive intestinal polypeptide-related peptides after pentylentetrazole-induced seizures in rat brain. Eur. J. Pharmacol. 229, 149-153.
165. Romualdi, P., Lesa, G., Donatini, A. and Ferri, S. (1995a) Long-term exposure to opioid antagonists up-regulates prodynorphin gene expression in rat brain. Brain Res. 672, 42-47.
166. Romualdi, P., Donatini, A., Bregola, G., Bianchi, C., Beani, L., Ferri, S. and Simonato, M. (1995b) Early changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures in the rat. Eur. J. Neurosci. 7, 1850-1856.
167. Romualdi, P., Donatini, A., Izenwasser, S., Cox, B. M. and Ferri, S. (1996) Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate-putamen. Mol. Brain Res. 40, 153-156.
168. Rosen, J. B., Cain, C. J., Weiss, S. R. B. and Post, R. M. (1992) Alterations in mRna of enkephalin, dynorphin and thyrotropin releasing hormone during amygdala kindling: an in situ hybridization study. Mol. Brain Res. 15, 247-255.
169. Salin, P. A., Weisskopf, M. G. and Nicoll, R. A. (1995) A comparison of the role of dynorphin in the hippocampal mossy fiber pathway in guinea pig and rat. J. Neurosci. 15, 6939-6945.
170. Sasek, C. A. and Elde, R. P. (1986) Coexistence of enkephalin and dynorphin immunoreactivities in neurons in the dorsal gray commissure of the sixth lumbar and first sacral spinal cord segments in rat. Brain Res. 381, 8-14.
171. Savage, D. D., Mills, S. A., Jobe, P. C. and Reigel, C. E. (1988) Elevation of naloxone-sensitive [3H]-dihydromorphine binding in hippocampal formation of genetically epilepsy-prone rats. Life Sci. 43, 239-246.
172. Schäfer, M. K.-H., Day, R., Akil, H. and Watson, S. J. (1990) Identification of prodynorphin and proenkephalin cells in the neurointermediate lobe of the rat pituitary gland. In: The international narcotics research conference (Irnc) '89, pp. 231-234. Eds. R. Quirion R., K. Jhamadas and C. Giounalakis. Liss: New York.
173. Seidah, N. G., Gaspar, L., Mion, P., Marcinkiewicz, M., Mbikay, M. and Chrétien, M. (1990) cDNA sequence of two distinct pituitary proteins homologous to kex2 and furin gene products: tissue specific mRNAs encoding candidates for prohormone processing proteinases. DNA 9, 415-424.
174. Seidah, N. G., Marcinkiewicz, M., Bejannet, S., Gaspar, L., Beaubien, G., Mattei, M. G., Lazure, C., Mbikay, M. and Chrétien, M. (1991) Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, furin, and kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. Mol. Endocrinol. 5, 111-122.
175. Seizinger, B. R., Höllt, V. and Herz, A. (1981) Evidence for the occurrence of the opioid octapeptide dynorphin-(1-8) in the neurointermediate pituitary of rats. Biochem. Biophys. Res. Commun. 102, 197-205.
176. Seizinger, B. R., Grimm, C., Höllt, V. and Herz, A. (1983) Evidence for a selective processing of pro-enkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary. J. Neurochem. 42, 447-457.
177. Sherman, T. G., Civelli, O., Douglass, J., Herbert, E., Burke, S. and Watson, S. J. (1986) Hypothalamic dynorphin and vasopressin mRNA expression in normal and Brattelboro rats. Fed. Proc. 45, 2323-2327.
178. Shin, C., Mcnamara, J. O., Morgan, J. I., Curran, T. and Cohen, D. R. (1990) Induction of c-fos mRNA expression by afterdischarge in the hippocampus of naive and kindled rats. J. Neurochem. 55, 1050-1055.
179. Shukla, V. K. and Lemaire, S. (1994) Non-opioid effects of dynorphins: possible role of the NMDA receptor. Trends Pharmacol. Sci. 15, 420-424.
180. Simmons, M. L., Terman, G. W., Gibbs, S. M. and Chavkin, C. (1995) L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells. Neuron 14, 1265-1272.
181. Simon, E. J., Hiller, J. M. and Edelman, I. (1973) Stereospecific binding of the potent narcotic analgesic 3H-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. USA 70, 1947-1949.
182. Simonato, M., Snead, O. C. and Jope, R. S. (1989) Electroencephalographic effects of intracerebroventricularly administered opioids: effect of lithium. Res. Comm. Psychol. Psych. Behav. 14, 207-223.
183. Simonato, M., Hosford, D. A., Labiner, D. M., Shin, C., Mansbach, H. H. and McNamara, J. O. (1991) Differential expression of immediate early genes in the hippocampus in the kindling model of epilepsy. Mol. Brain Res. 11, 115-124.
184. Simonato, M., Bregola, G., Donatini, A., Bianchi, C., Beani, L., Ferri, S. and Romualdi, P. (1996) Kindled seizure-induced c-fos and prodynorphin mRna expressions are unrelated in the rat brain. Eur. J. Neurosci. 8, 2064-2067.
185. Singh, L., Vass, C. A., Hunter, J. C., Woodruff, G. N. and Hughes, J. (1990) The anticonvulsant action of CI-977, a selective κ-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex. Eur. J. Pharmacol. 191, 477-480.
186. Smeekens, S. P., Avruch, A. S., Lemendola, J., Chan, S. J. and Steiner, D. F. (1991) Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans. Proc. Natl. Acad. Sci. USA 88, 340-344.
187. Smith, F. L. and Dewey, W. L. (1993) Endogenous dynorphin modulates calcium-mediated antinociception in mice. Pharmacol. Biochem. Behav. 45, 383-391.
188. Snead, O. C. (1983) On the sacred disease: the neurochemistry of epilepsy. Int. Rev. Neurobiol. 24, 93-180.
189. Snead, O. C. and Bearden, L. J. (1980) Anticonvulsants specific for petit mal antagonize epileptogenic effect of leu-enkephalin. Science 210, 1031-1033.
190. Snead, O. C. and Simonato, M. (1991) Opioid peptides and seizures. In: Neurotransmitters and epilepsy, pp. 181-200. Eds. R. S. Fisher and J. Coyle. Wiley-Liss Inc.: New York.
191. Song, Z. H. and Takemori, A. E. (1992) Stimulation by corticotropin-releasing factor of the release of immunoreactive dynorphin A from mouse spinal cords in vitro. Eur. J. Pharmacol. 222, 27-32.
192. Sonnenberg, J. L., MacGregor-Leon, P. F., Curran, T. and Morgan, J. I. (1989) Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron 3, 359-365.
193. Spampinato, S. and Candeletti, S. (1985) Characterization of dynorphin A-induced antinociception at spinal level. Eur. J. Pharmacol. 110, 21-30.
194. Spampinato, S., Canossa, M., Campana, G., Carboni, L. and Bachetti, T. (1995) Estrogen regulation of prodynorphin gene expression in the rat adenohypophisis: effect of the anti-estrogen tamoxifen. Endocrinology 136, 1589-1594.
195. Steiner, H. and Gerfen, C. R. (1995) Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J. Comp. Neurol. 353, 200-212.
196. Stenfors, C., Srinivasan, G. R., Theodorsson, E. and Mathe, A. A. (1992) Electroconvulsive stimuli and brain peptides: effect of modification of seizure duration on neuropeptide Y, neurokinin A, substance P and neurotensin. Brain Res. 596, 251-258.
197. Sutula, T., Xiao-Xian, H., Cavazos, J. and Scott, G. (1988) Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science 239, 1147-1150.
198. Sutula, T., Cascino, G., Cavazos, J., Parada, I. and Ramirez, L. (1989) Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 26, 321-330.
199. Swinyard, E. A., (1972) Electrically induced convulsions. In: Experimental models of epilepsy - A manual for the laboratory worker, pp. 435-458. Eds. D. P. Purpura, J. K. Penry, D. M. Woodbury, D. B. Tower and R. D. Walter. Raven Press: New York.
200. Tauck, D. L. and Nadler, J. V. (1985) Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J. Neurosci. 5, 1016-1022.
201. Tempel, A. and Zukin, R. S. (1987) Neuroanatomical patterns of the mu, delta and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. USA 84, 4308-4312.
202. Terenius, L. (1973) Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fractions from rat brain. Acta Pharmacol. Toxicol. 33, 377-384.
203. Terrian, D. M., Johnston, D., Claiborne, B. J., Ansah-Yiadom, R., Strittmatter, W. J. and Rea, M. A. (1988) Glutamate and dynorphin release from a subcellular fraction enriched in hippocampal mossy fiber synaptosomes. Brain Res. Bull. 21, 343-351.
204. Theodore, W. H., Carson, R. E., Andreasen, P., Zametkin, A., Blasberg, R., Leiderman, D. B., Rice, K., Newman, A., Channing, M., Dunn, B., Simpson, N. and Herscovitch, P. (1992) Pet imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy. Epilepsy Res. 13, 129-139.
205. Tortella, F. C. (1988) Endogenous opioid peptides and epilepsy: quiting the seizing brain?. Trends Pharmacol. Sci. 9, 366-372.
206. Tortella, F. C. (1993) Opioids: epilepsy and neuroprotection. In: Opioids I, Vol. I, pp. 343-360. Ed. A. Herz. Springer-Verlag: Berlin.
207. Tortella, F. C. and Long, I. B. (1985) Endogenous anticonvulsant substance in rat cerebrospinal fluid after a generalized seizure. Science 228, 1106-1108.
208. Tortella, F. C., Robles, L. and Holaday, J. W. (1986) U50,488, a highly selective kappa opioid: anticonvulsant profile in rats. J. Pharmacol. Exp. Ther. 237, 49-53.
209. Tortella, F. C., Robles, L. and Holaday, J. W. (1987) Evidence for mu opioid receptor mediation of enkephalin-induced electrographic seizures. J. Pharmacol. Exp. Ther. 240, 571-577.
210. Tortella, F. C., Echevarria, E., Lipkowski, A. W., Takemori, A. E., Portoghese, P. S. and Holaday, J. W. (1989) Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model. Life Sci. 44, 661-665.
211. Tortella, F. C., Robles, L., Echevarria, E., Hunter, J. C. and Hughes, J. (1990) Protects against NMDA and maximal electroshock convulsions in rats. Life Sci. 46, P11-7.
212. Trujillo, K. A. and Akil, H. (1990) Opioid and non-opioid behavioral actions of prodynorphin A and the dynorphin analogue Dakli. Natl. Inst. Drug Abuse Res. Monogr. Ser. 105, 397-398.
213. Urca, G., Frenk, H., Liebeskind, J. C. and Taylor, A. N. (1977) Morphine and enkephalin: analgesic and epileptic properties. Science 197, 83-86.
214. VonVoigtlander, P. F., Hall, E. D., Camacbo Ochoa, M., Lewis, R. A. and Triezenberg, H. J. (1987) U-54494A: a unique anticonvulsant related to kappa opioid agonists. J. Pharmacol. Exp. Ther. 243, 542-547.
215. Wagner, J. J., Terman, G. W. and Chavkin, C. (1993) Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 363, 451-454.
216. Walczak, T. S., Radtke, R. A., McNamara, J. O., Lewis, D. V., Luther, J. S., Thompson, E., Wilson, W. P., Friedman, A. H. and Nashold, B. S. (1990) Anterior temporal lobectomy for complex seizures: evaluation, results, and long-term follow-up in 100 cases. Neurology 40, 413-418.
217. Watson, S. and Girdlestone, D. (1996) 1996 receptor and ion channel nomenclature supplement. Trends Pharmacol. Sci. 18, suppl., 51-52.
218. Watson, S. J. A., Akil, H., Ghazarossian, V. E. and Goldstein, A. (1981) Dynorphin immunocytochemical localization in brain and peripheral nervous system: preliminary studies. Proc. Natl. Acad. Sci. USA 78, 1260-1263.
219. Watson, S. J., Khachaturian, H., Akil, H., Coy, D. H. and Goldstein, A. (1982) Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science 218, 1134-1136.
220. Watson, S. J., Khachaturian, H., Taylor, L., Fischli, W., Goldstein, A. and Akil, H. (1983) Prodynorphin peptides are found in the same neurones throughout rat brain. Immunocytochemical study. Proc. Natl. Acad. Sci. USA 80, 891-894.
221. Weisskopf, M. G., Zalutsky, R. A. and Nicoll, R. A. (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362, 423-427.
222. White, J. D. and Gall, C. M. (1987) Differential regulation of neuropeptide and proto-oncogene mRNA content in the hippocampus following recurrent seizures. Mol. Brain Res. 3, 21-29.
223. Xie, C. W., Lee, P. H. K., Douglass, J., Crain, B. and Hong, J. S. (1989a) Deep prepyriform cortex kindling differentially alters the levels of prodynorphin mRNA in rat hippocampus and striatum. Brain Res. 495, 156-160.
224. Xie, C. W., Lee, P. H. K., Takeuchi, K., Owyang, V., Li, S. J., Douglass, J. and Hong, J. S. (1989b) Single and repeated electroconvulsive shocks alter the levels of prodynorphin and proenkephalin mRNAs in rat brain. Mol. Brain Res. 6, 11-19.
225. Xie, C. W., McGinty, J. F., Lee, P. H. K., Mitchell, C. L. and Hong, J. S. (1991) A glutamate antagonist blocks perforant stimulation-induced reduction of dynorphin peptide and prodynorphin mRNA levels in rat hippocampus. Brain Res. 562, 243-250.
226. Xue, J. I., Yu, Y. X., Han, J. S. and Jen, M. F. (1995) Changes in the content of immunoreactive dynorphin in dorsal and ventral spinal cord of the rat in three different conditions. Int. J. Neurosci. 82, 95-104.
227. Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Reisine, T. and Bell, G. I. (1993) Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90, 6736-6740.
228. Yeh, G. C., Bonhaus, D. W., Nadler, J. V. and McNamara, J. O. (1989) N-methyl-D-aspartate receptor plasticity in kindling: quantitative and qualitative alterations in the N-methyl-D-aspertate receptor-channel complex. Proc. Natl. Acad. Sci. USA 86, 8157-8160.
229. You, Z. B., Herrera-Marschitz, M., Nylander, I., Goiny, M., O'Connor, W. T., Ungerstedt, U. and Terenius, L. (1994a) The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis. Effects of dopamine D1 and D2 receptor agonists. Neuroscience 63, 427-434.
230. You, Z. B., Pettersson, E., Herrera-Marschitz, M., Hokfelt, T., Terenius, L., Nylander, I., Goiny, M., Hughes, J., O'Connor, W. T. and Ungerstedt, U. (1994b) Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis. Neuroreport 5, 2301-2304.
231. Yount, G. L., Ponsalle, P. and White, J. D. (1994) Pentylentetrazole-induced seizures stimulate trasncription of early and late response genes. Mol. Brain Res. 21, 219-224.
232. Zhang, S. and Yu, L. (1995) Identification of dynorphins as endogenous ligands for and opioid receptor-like orphan receptor. J. Biol. Chem. 270, 22772-22776.
233. Zukin, R. S-, Eghabli, M., Olive, D., Unterwald, E. M. and Tempel, A. (1988) Characterization and visualization of rat and guinea pig kappa opioid receptors: evidence for κ1 and κ2 opioid receptors. Proc. Natl. Acad. Sci. USA 85, 4061-4065.